Frost & Sullivan Co-Organise With AMIP to Host Healthcare Meeting to Discuss Growth Opportunities and Challenges in the Pharmaceutical Industry and Digital Health Tech Readiness in Morocco
Shaheennews –
Frost & Sullivan has co-organised with AMIP (Moroccan Pharmaceutical Industry Association) to host its very first Healthcare Meeting on December 4, 2018 at the Hyatt Regency Hotel, Casablanca, Morocco.
2018 will be a tipping point for mainstream adoption of popular digital health tech/solutions and the transition of noble technologies from research/proof-of-concept to actionable healthcare and clinical applications. Envisaging huge growth opportunities, Frost & Sullivan will host the meeting and discuss the global trends and the growth opportunities in the healthcare and life sciences sector.
At the start of every year, Frost & Sullivan’s Transformational Health team brainstorms top predictions in the healthcare space. Despite on-going political uncertainties and rising cost pressures, the global healthcare industry will register a stable growth rate in 2018 and will cross the $1.85 trillion mark in terms of manufacturer revenues. Digital health investments crossed $6.5 billion in 2017, up to 109% from the previous year. This growth curve is expected to continue in 2018 as technologies and platform solutions that promote innovation around care quality, outcomes, and chronic disease management will continue to rise. High growth opportunities in emerging markets will change the paradigms of product development and geographic rollouts.
The Frost & Sullivan Healthcare and Life Sciences experts are predicting big disruptions, transformations and innovations in the coming years as the healthcare industry continues to overhaul outmoded business models.
“Our interactive workshop is designed to help managers and CEOs understand key issues affecting the healthcare industry globally,” noted Sandeep Sinha, Vice President & Head, Healthcare and Life Sciences, Frost & Sullivan. “Advances in areas ranging from cancer immunotherapy products to blood testing, as well as the convergence of cutting-edge technology such as artificial intelligence and blockchain will help shape the healthcare industry into a much-anticipated, value-based care paradigm.”
